Brooke L. Griffin, PharmD, BCACP

home / authors / brooke-l-griffin-pharmd-bcacp

Articles

Make This Year Your Best Year in Pharmacy School

Make This Year Your Best Year in Pharmacy School

Brooke L. Griffin, PharmD, BCACP
November 16th 2021

Read More

Addressing Immunizations in Pregnant and Lactating Women

Addressing Immunizations in Pregnant and Lactating Women

Brooke L. Griffin, PharmD, BCACP;Kathleen M. Vest, PharmD, CDE, BCACP
August 12th 2019

The immunization status of pregnant and lactating women should be routinely assessed, and indicated vaccines should be recommended.

Read More

Hormonal Contraceptive Prescribing By Pharmacists: A Brief Overview

Hormonal Contraceptive Prescribing By Pharmacists: A Brief Overview

Autumn Stewart-Lynch, PharmD, BCACP, CTTS;Brooke L. Griffin, PharmD, BCACP
May 1st 2018

Pharmacists in all practice settings have opportunities to assist patients who use or seek to use contraception.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD